R1	Has_index Arg1:T2 Arg2:T3	
R2	Has_temporal Arg1:T1 Arg2:T2	
*	OR T6 T7
R3	Has_value Arg1:T9 Arg2:T10	
R4	AND Arg1:T8 Arg2:T9	
R5	Has_value Arg1:T11 Arg2:T12	
R6	Has_qualifier Arg1:T13 Arg2:T14	
R7	Has_value Arg1:T17 Arg2:T18	
R8	Has_value Arg1:T19 Arg2:T20	
*	OR T17 T19
R9	Has_value Arg1:T15 Arg2:T16	
R10	Subsumes Arg1:T15 Arg2:T17	
R11	AND Arg1:T13 Arg2:T15	
*	OR T22 T23
R12	Has_temporal Arg1:T24 Arg2:T25	
*	OR T30 T31
R13	Subsumes Arg1:T29 Arg2:T30	
*	OR T26 T28 T27 T29
R14	Subsumes Arg1:T24 Arg2:T26	
*	OR T34 T36 T35
*	OR T38 T39 T40 T41
R15	Subsumes Arg1:T37 Arg2:T38	
*	OR T44 T45
R16	Has_qualifier Arg1:T43 Arg2:T44	
R17	Has_temporal Arg1:T43 Arg2:T46	
R18	Has_qualifier Arg1:T51 Arg2:T52	
*	OR T48 T49 T51
R19	Has_qualifier Arg1:T49 Arg2:T50	
R20	Has_temporal Arg1:T48 Arg2:T53	
R21	Subsumes Arg1:T51 Arg2:T55	
R22	Has_qualifier Arg1:T56 Arg2:T57	
R23	Has_qualifier Arg1:T58 Arg2:T59	
*	OR T58 T60
R24	Subsumes Arg1:T56 Arg2:T58	
R25	Has_qualifier Arg1:T62 Arg2:T63	
R26	Has_temporal Arg1:T62 Arg2:T64	
*	OR T65 T66
R27	Has_qualifier Arg1:T68 Arg2:T69	
*	OR T67 T68
*	OR T70 T71 T72 T73
R28	Subsumes Arg1:T72 Arg2:T74	
R29	Subsumes Arg1:T68 Arg2:T70	
R30	Has_qualifier Arg1:T77 Arg2:T78	
*	OR T81 T83 T82 T84
R31	AND Arg1:T80 Arg2:T81	
T1	Device 27 30	PCI
T2	Temporal 31 58	< 60 minutes from diagnosis
T3	Reference_point 49 58	diagnosis
T4	Non-query-able 79 147	inability to arrive at the catheterisation laboratory within 3 hours
T5	Procedure 158 162	CABG
T6	Condition 164 188	Left bundle branch block
T7	Condition 192 210	ventricular pacing
T8	Condition 226 243	cardiogenic shock
T9	Measurement 246 258	Killip Class
T10	Value 259 260	4
T11	Measurement 278 289	body weight
T12	Value 290 297	< 55 kg
T13	Condition 333 345	hypertension
T14	Qualifier 320 332	Uncontrolled
T15	Measurement 368 382	blood pressure
T16	Value 383 398	= 180/110 mm Hg
T17	Measurement 400 411	systolic BP
T18	Value 412 423	= 180 mm Hg
T19	Measurement 431 443	diastolic BP
T20	Value 444 455	= 110 mm Hg
T22	Condition 493 499	stroke
T23	Condition 503 506	TIA
T24	Drug 550 565	anticoagulation
T25	Temporal 566 581	within 12 hours
T26	Drug 593 615	unfractionated heparin
T27	Drug 617 627	enoxaparin
T28	Drug 636 647	bivalirudin
T29	Drug 666 686	oral anticoagulation
T30	Drug 693 701	warfarin
T31	Drug 707 712	NOACs
T34	Condition 715 730	Active bleeding
T35	Condition 740 757	bleeding disorder
T36	Condition 758 767	diathesis
T37	Condition 786 815	central nervous system damage
T38	Condition 822 830	neoplasm
T39	Condition 832 840	aneurysm
T40	Procedure 842 854;865 872	intracranial surgery
T41	Procedure 858 872	spinal surgery
T43	Condition 884 890	trauma
T44	Qualifier 898 902	head
T45	Qualifier 906 913	cranium
T46	Temporal 920 930	< 3 months
T48	Procedure 933 946	Major surgery
T49	Procedure 948 954	biopsy
T50	Qualifier 960 977	parenchymal organ
T51	Condition 994 1000	trauma
T52	Qualifier 982 993	significant
T53	Temporal 1012 1025	past 2 months
T55	Condition 1080 1101	myocardial infarction
T56	Observation 1149 1165	risk of bleeding
T57	Qualifier 1139 1148	increased
T58	Condition 1189 1206	peptic ulceration
T59	Qualifier 1182 1188	active
T60	Condition 1214 1222	neoplasm
T62	Condition 1263 1292	cardiopulmonary resuscitation
T63	Qualifier 1253 1262	Prolonged
T64	Temporal 1318 1330	past 2 weeks
T65	Condition 1338 1356	acute pericarditis
T66	Condition 1364 1395	subacute bacterial endocarditis
T67	Condition 1403 1421	acute pancreatitis
T68	Condition 1438 1457	hepatic dysfunction
T69	Qualifier 1431 1437	severe
T70	Condition 1469 1484	hepatic failure
T71	Condition 1486 1495	cirrhosis
T72	Condition 1497 1516	portal hypertension
T73	Condition 1543 1559	active hepatitis
T74	Condition 1518 1537	oesophageal varices
T76	Condition 1561 1569	Dementia
T77	Condition 1584 1603	renal insufficiency
T78	Qualifier 1577 1583	severe
T79	Competing_trial 1605 1737	Previous enrolment in this study or treatment with an investigational drug or device under another study protocol in the past 7 days
T80	Condition 1745 1763	allergic reactions
T81	Drug 1767 1779	tenecteplase
T82	Drug 1781 1792	clopidogrel
T83	Drug 1794 1804	enoxaparin
T84	Drug 1809 1816	aspirin
T86	Post-eligibility 1818 2023	Inability to follow the protocol and comply with follow-up requirements or any other reason that the investigator feels would place the patient at increased risk if the investigational therapy is initiated
